Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0218 | 0 | 0.5 | |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0307 | 1 | 0.5 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0307 | 1 | 0.5 |
Loa Loa (eye worm) | thymidylate synthase | 0.0218 | 0 | 0.5 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0307 | 1 | 0.5 |
Echinococcus granulosus | thymidylate synthase | 0.0218 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0218 | 0 | 0.5 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0307 | 1 | 0.5 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0307 | 1 | 0.5 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0218 | 0 | 0.5 |
Mycobacterium ulcerans | thymidylate synthase | 0.0218 | 0 | 0.5 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0218 | 0 | 0.5 |
Brugia malayi | thymidylate synthase | 0.0218 | 0 | 0.5 |
Echinococcus multilocularis | thymidylate synthase | 0.0218 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | = 38 uM | In vitro concentration required to induce apoptosis in HL60 cells | ChEMBL. | 12877593 |
AC50 (functional) | = 38 uM | In vitro concentration required to induce apoptosis in HL60 cells | ChEMBL. | 12877593 |
IC50 (functional) | = 20 uM | In vitro inhibitory concentration against proliferation of HL60 cells | ChEMBL. | 12877593 |
IC50 (functional) | = 20 uM | In vitro inhibitory concentration against proliferation of HL60 cells | ChEMBL. | 12877593 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.